Data as of Nov 17, 2026 close · Source: Financial Modeling Prep (methodology)
Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Cytosorbents Corporation (CTSO), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
-0.91
P/B ratioShare price divided by book value per share.
-6.64
P/S ratioMarket value divided by annual revenue.
0.41
PEG ratioP/E divided by the earnings growth rate.
0.01
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
-3.38
EV / RevenueEnterprise value against annual revenue.
1.09
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
-109.89%
Free cash flow yieldFree cash flow as a percentage of market value.
-52.90%
Price / free cash flowMarket value divided by free cash flow.
-1.89
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
72.91%
Operating marginRevenue left after operating costs.
-28.63%
Net marginRevenue left after every cost, including tax and interest.
-45.05%
Return on equityProfit as a percentage of shareholders’ equity.
-133.33%
Return on assetsProfit as a percentage of total assets.
-45.42%
Return on capital employedOperating profit against the capital the business uses.
-117.49%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
0.55
Quick ratioThe same, excluding inventory.
0.44
Cash ratioCash alone against current liabilities.
0.60
Debt to equityTotal borrowings against shareholders’ equity.
-12.81
Debt to assetsTotal borrowings against total assets.
0.66
Interest coverageHow many times operating profit covers the interest bill.
-6.50
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
−$2.60
Book value per shareShareholders’ equity divided by shares outstanding.
−$0.73
Market capitalisationShare price times shares outstanding.
$14.24M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$41.35M
EmployeesReported headcount.
149
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
Cytosorbents Corporation (CTSO) trades on a price-to-earnings ratio of -0.91. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.
What is Cytosorbents Corporation's return on equity?
Cytosorbents Corporation (CTSO) reports a return on equity of -133.33%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Cytosorbents Corporation carry?
Cytosorbents Corporation (CTSO) has a debt-to-equity ratio of -12.81, which compares total borrowings with shareholders' equity.
What is Cytosorbents Corporation's profit margin?
Cytosorbents Corporation (CTSO) keeps -45.05% of revenue as net profit after every cost, including tax and interest.